Literature DB >> 22037657

Letter to the Editor on: A. Siegmann et al. Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival. Results of a retrospective study. In: Strahlenther Onkol 2011;187:467-72 (No. 8) (DOI 10.1007/s00066-011-2229-3). P. Ghadjar, D. Zwahlen, D.M. Aebersold: Selection bias is not a good reason for dose intensification in patients with PSA recurrence after radical prostatectomy.

Pirus Ghadjar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22037657     DOI： 10.1007/s00066-011-9229-1

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  4 in total

1.  Later outcomes and alpha/beta estimate from hypofractionated conformal three-dimensional radiotherapy versus standard fractionation for localized prostate cancer.

Authors:  Felix Leborgne; Jack Fowler; José H Leborgne; Julieta Mezzera
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-07       Impact factor: 7.038

2.  Deriving prostate alpha-beta ratio using carefully matched groups, long follow-up and the phoenix definition of biochemical failure.

Authors:  Richard Shaffer; Tom Pickles; Richard Lee; Vitali Moiseenko
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-16       Impact factor: 7.038

3.  Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective study.

Authors:  Alessandra Siegmann; Dirk Bottke; Julia Faehndrich; Gunnar Lohm; Kurt Miller; Detlef Bartkowiak; Thomas Wiegel; Wolfgang Hinkelbein
Journal:  Strahlenther Onkol       Date:  2011-07-22       Impact factor: 3.621

Review 4.  The radiobiology of prostate cancer including new aspects of fractionated radiotherapy.

Authors:  Jack F Fowler
Journal:  Acta Oncol       Date:  2005       Impact factor: 4.089
  4 in total
  1 in total

1.  Dose-escalated salvage radiotherapy after radical prostatectomy in high risk prostate cancer patients without hormone therapy: outcome, prognostic factors and late toxicity.

Authors:  Mohamed Shelan; Yasser Abo-Madyan; Grit Welzel; Christian Bolenz; Julia Kosakowski; Nadim Behnam; Frederik Wenz; Frank Lohr
Journal:  Radiat Oncol       Date:  2013-11-27       Impact factor: 3.481
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.